MedDataX Logo

Medical Utilization in Israel During Second Intifada

NCT ID: NCT00350675

Last Updated: 2006-07-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Study Classification

OBSERVATIONAL

Study Start Date

2006-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this ecological study we examine the impact of stress from repeated terrorist attacks during the second initifada on medical utilization by the Israeli population. We hypothesize that in weeks following serious terror attacks there will be an increase in prescriptions for psychiatric medications and an increased number of unexplained somatic complaints. We will also examine associations with overall medical utlization. We will consider age, gender and effects of geographic poximity to location of attacks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Depression Stress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

DEFINED_POPULATION

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Ecological study We will examine patterns of visits and prescirptions for all participants in two large health provider institutions in Israel.

Exclusion Criteria

None - ecological study
Minimum Eligible Age

0 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sheba Medical Center

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joshua D Lipsitz, PhD

Role: PRINCIPAL_INVESTIGATOR

Gertner Institute, Sheba Medical Center

Raz Gross, MD

Role: STUDY_CHAIR

Gertner Institute, Sheba Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joshua D Lipsitz, PhD

Role: CONTACT

Phone: 972-3-530-3505

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SHEBA-06-4194-RG-CTIL

Identifier Type: -

Identifier Source: org_study_id